Choosing Between BCA, Bradford, and Fluorescence Assays

Protein quantification is one of those tasks that looks like a solved problem until you get an unexpected result and have to work backwards to find out why. BCA, Bradford, and fluorescence-based methods each have genuine strengths, and each has specific conditions under which they give unreliable numbers. Choosing the right one for your sample type is not complicated, but it does require knowing what is in your sample.

BCA: the workhorse with a temperature sensitivity ¶

The bicinchoninic acid assay is the most widely used protein quantification method in routine laboratory work, and for good reason. It is compatible with most detergents, it is relatively insensitive to variation in protein composition, and the protocol is straightforward. The main limitation is that the colour development step requires incubation at 37 degrees Celsius, and the signal continues to develop after the incubation ends. Plates need to be read promptly and at a consistent temperature.

Reducing agents. Dithiothreitol and beta-mercaptoethanol in particular. Interfere with BCA at concentrations above about 1 mM. If your lysis buffer contains reducing agents, either dilute the sample sufficiently to bring the agent below the interference threshold, or switch to a method that is not affected.

Bradford: fast, but protein-composition-dependent ¶

The Bradford assay is faster than BCA and does not require a heating step, which makes it useful when throughput matters. The limitation is that the Coomassie dye binds preferentially to arginine and aromatic amino acids, so the signal you get depends partly on the amino acid composition of your protein mixture. For a purified single protein, this is manageable. You can use the same protein as your standard. For a complex lysate, the Bradford assay can give results that differ from BCA by 20% or more, and neither is necessarily wrong; they are measuring slightly different things.

Fluorescence-based methods: sensitivity when you need it ¶

Fluorescence-based assays. The most common being those that use dyes which fluoresce on binding to protein. Offer sensitivity roughly ten times higher than BCA or Bradford. This matters when sample volume is limited or protein concentration is very low, as is often the case with cerebrospinal fluid or small tissue biopsies.

The trade-off is that fluorescence assays are more sensitive to matrix effects and require a plate reader with the appropriate excitation and emission filters. They are also more expensive per sample than BCA or Bradford. For routine work on cell lysates at standard concentrations, the added sensitivity is usually unnecessary. For low-abundance samples, it is often the only method that gives a usable result.

A practical decision framework ¶

Start with BCA unless your sample contains high concentrations of reducing agents or you are working with very low protein concentrations. If reducing agents are unavoidable, Bradford is a reasonable alternative for purified proteins. If your sample volume is below 5 microlitres or your expected concentration is below 1 microgram per millilitre, a fluorescence-based method is worth the additional cost and setup time.

• BCA: general purpose, detergent-compatible, avoid with reducing agents above 1 mM
• Bradford: fast, good for purified proteins, less reliable for complex lysates
• Fluorescence: high sensitivity, best for low-volume or low-concentration samples

If you are unsure which method is appropriate for your specific matrix, it is worth running a small comparison experiment before committing to a method for a full study. The difference in results can be significant, and it is better to find that out at the start.